Merck & Co
US.MRK
150.33
-2.01
-1.32%
Merck & Co
150.33
-2.01
-1.32%
Collector offline (last heartbeat: 19217s ago)
· 2026-09-04 20:02
Pre-market
150.87
-0.96%
After-hours
150.51
+0.12%
Overnight
151.61
-0.48%
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 15 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 81.59%
- Institutions
- 4,340 -15
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund68.42%
Public Company4.80%
Private Company2.44%
Government Pension Fund2.09%
Sovereign Wealth Fund1.59%
Hedge Fund1.06%
Family Office/Trust0.46%
Insurance Company0.25%
Corporate Pension Plan0.19%
Other18.70%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 9.20% |
| Vanguard Capital Management, LLC | 7.10% |
| State Street Global Advisors | 4.88% |
| Wellington Management Group | 3.50% |
| Vanguard Portfolio Management, LLC | 2.75% |
| Other | 72.58% |
Insiders
28 filings tracked · 12 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Robert Davis | Chairperson & CEO | 0.02% |
| Sanat Chattopadhyay | Executive VP & President of Merck Manufacturing Division | 0.01% |
| Richard DeLuca | Executive VP & President of Merck Animal Health | 0.00% |
| Dean Li | Executive VP & President of Merck Research Laboratories | 0.00% |
| Caroline Litchfield | Chief Financial Officer | 0.00% |
| Jennifer Zachary | Executive Vice President | 0.00% |
| Chirfi Guindo | Senior VP & Chief Marketing Officer for Merck Human Health | 0.00% |
| David Williams | Executive VP and Chief Information & Digital Officer | 0.00% |
| Joseph Romanelli | Senior VP & President of Human Health International | 0.00% |
| David Maraldo | Executive VP & President of Merck Manufacturing Division | 0.00% |
Quote time 2026-09-04 20:02:22
For reference only, not investment advice.